Malignant Ovarian Neoplasm — Trials

Malignant Ovarian Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,086 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 684
Recruiting: 385
Ph III recruiting: 46
Growth YoY: +9.8%
Industry share: 37%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.8%
Trials / 1,000 deaths: 53.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (437)

clinicaltrialsPublishedShowing 101–108 of 108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00173407	PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion	withdrawn	N/A	0	National Taiwan University HospitalOTHER	1	Dec 27, 2012	clinicaltrials
NCT00460200	Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer	withdrawn	—	0	Jonsson Comprehensive Cancer CenterOTHER	0	Oct 4, 2012	clinicaltrials